High affinity binding of azasetron hydrochloride to 5-hydroxytryptamine3 receptors in the small intestine of rats

Japanese Journal of Pharmacology

Volumn 73, Issue 4, 1997, Pages 357-360

  Katayama, Ken Ichi ^a   Asano, Kiyoshi ^a   Haga, Keiichiro ^a   Fukuda, Takemi ^a  

^a Research Laboratories   (Japan)

Author keywords

5 HT3 receptor; Azasetron; Small intestine

Indexed keywords

2 METHYLSEROTONIN; 5 METHOXYTRYPTAMINE; AZASETRON; CISAPRIDE; GRANISETRON; KETANSERIN; METHYSERGIDE; METOCLOPRAMIDE; ONDANSETRON; SEROTONIN; SEROTONIN 3 RECEPTOR; TROPISETRON; ZACOPRIDE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG COMPETITION; DRUG POTENCY; DRUG RECEPTOR BINDING; MALE; NONHUMAN; RADIORECEPTOR ASSAY; RAT; RECEPTOR AFFINITY; SMALL INTESTINE;

EID: 0030954606     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.73.357     Document Type: Article

References (15)

1. Cubeddu LX, Hoffmann IS, Fuenmayor NT and Finn AL: Efficacy of ondansetron (GR38032F) and the role of serotonin in cisplatin induced nausea and vomiting. N Engl J Med 322, 810-816 (1990)
2. Costall B, Domeney AM, Naylor RJ and Tattersall FD: Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs. Neuropharmacology 26, 1321-1326 (1987)
3. 3 receptors mediate cisplatin-induced emesis in dogs. Jpn J Pharmacol 59, 221-226 (1992)
4. Fukui H, Yamamoto M, Ando T, Sakaki S and Sato S: Increase in serotonin levels in the dog ileum and blood by cisplatin as measured by microdialysis. Neuropharmacology 32, 959-968 (1993)
5. Andrews PLR, Rapeport WG and Sanger GJ: Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol Sci 9, 334-341 (1988)
6. Inaba K, Morimoto Y, Fukuda T and Setoguchi M: Inhibition by Y-25130 of the von Bezold-Jarisch effect evoked by 5-HT or 2-methyl-5-HT in anesthetized rats. Folia Pharmacol Jpn 98, 293-299 (1991) (Abstr in English)
7. 3 receptors. Jpn J Pharmacol 59, 443-448 (1992)
8. 3 receptor-mediated currents in dissociated frog sensory neurones by benzoxazine derivative, Y-25130. Br J Pharmacol 107, 853-857 (1992)
9. 3 receptor antagonist. Eur J Pharmacol 196, 299-305 (1991)
10. 3-receptor antagonist, on chemotherapeutic agent-induced emesis. Jpn J Pharmacol 63, 377-383 (1993)
11. Niitani H, Ota K, Taguchi T, Takeuchi S, Tsukagoshi S, Furue H, Furuse K, Machida T, Wakui A, Sakuma A, Sakurai Y and Tominaga T: Clinical evaluation of Y-25130 against nausea and vomiting induced by anticancer drugs: Multi-centered, placebo-controlled, double-blind comparative study. Jpn Pharmacol Ther 20, 2525-2542 (1992)
12. Sakamori M, Takehara S and Setoguchi M: High affinity binding of Y-25130 for serotonin 3 receptor. Folia Pharmacol Jpn 100, 137-142 (1992) (Abstr in English)
13. Bradford M: A rapid and sensitive method for quantitation of microgram quantities of proteins utilizing the principles of protein-dye binding. Anal Biochem 72, 248-254 (1976)
14. 50) of an enzymatic reaction. Biochem Pharmacol 22, 3099-3108 (1973)
15. 3 binding sites in rat brain cortical membranes. Biochem Pharmacol 38, 1693-1695 (1989)